Pegsunercept


Pegsunercept is a drug for the treatment of rheumatoid arthritis., Phase II clinical trials have been completed. It is being developed by Amgen.
Similarly to etanercept, pegsunercept is a soluble tumor necrosis factor receptor. Pegsunercept is a PEGylated protein.